Search

Author/Creator Lai, C.

18. Modulation of the Wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease-modifying approach for knee osteoarthritis treatment. Issue 9 (September 2019)

Authors:
Deshmukh, V.; O'Green, A.L.; Bossard, C.; Seo, T.; Lamangan, L.; Ibanez, M.; Ghias, A.; Lai, C.; Do, L.; Cho, S.; Cahiwat, J.; Chiu, K.; Pedraza, M.; Anderson, S.; Harris, R.; Dellamary, L.; KC, S.; Barroga, C.; Melchior, B.; Tam, B.
Journal:
Osteoarthritis and cartilage
Issue:
Volume 27:Issue 9(2019)
Page Start:
1347
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

20. P519: TRANSFUSION INDEPENDENCE AMONG NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS RECEIVING VENETOCLAX-BASED COMBINATIONS VS OTHER THERAPIES: RESULTS FROM THE AML REAL WORLD EVIDENCE (ARC) INITIATIVE. (23rd June 2022)

Authors:
Wolach, O.; Garcia, J. S.; Vachhani, P.; Zeidner, J.; Lai, C.; Moshe, Y.; Xavier, M.; Lee, S.; Zuckerman, T.; Pollyea, D. A.; Abedin, S.; Chen, E. C.; Bathini, S.; Edwards, W.; Bui, C. N.; Cheng, W. W.-H.; Svensson, A.; Guérin, A.; Maitland, J.; Ma, E.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
418
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗